COMMUNIQUÉS West-GlobeNewswire

Eton Pharmaceuticals Reports First Quarter 2019 Financial Results and Highlights Business Progress
07/05/2019
– Four Products Currently Under Review with the FDA – – Expecting Multiple Product Launches in Second Half of 2019 – – Company to Host Conference Call and Webcast today at 4:30 p.m. ET (3:30 p.m. CT) - DEER PARK, Ill., [...]
Autolus Therapeutics to Report First Quarter 2019 Financial Results and Host Conference Call on May 14
07/05/2019
LONDON, May 07, 2019 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that it will release [...]
CohBar Reports First Quarter 2019 Financial Results and Business Update
07/05/2019
Company to host conference call and webcast today, May 7, at 5:00 p.m. EDT MENLO PARK, Calif., May 07, 2019 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria [...]
Ascendis Pharma A/S Announces Participation in the Bank of America Merrill Lynch 2019 Healthcare Conference
07/05/2019
COPENHAGEN, Denmark, May 07, 2019 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technologies to address unmet medical needs, today announced [...]
Editas Medicine Announces First Quarter 2019 Results and Update
07/05/2019
- Building on focus in oncology through newly-formed partnership with BlueRock Therapeutics to develop universal allogeneic cell medicines for cancer - - EDIT-101 (AGN-151587) for LCA10 on track for first patient dosing [...]
Retrophin Reports First Quarter 2019 Financial Results
07/05/2019
Top-line results from pivotal Phase 3 FORT Study in PKAN on-track for 3Q 2019 Enrollment ongoing in Phase 3 clinical trials of sparsentan for patients with rare nephropathies FSGS and IgAN Continued quarter over quarter [...]
Principia Biopharma Reports First Quarter Financial Results
07/05/2019
SOUTH SAN FRANCISCO, Calif., May 07, 2019 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company dedicated to bringing transformative oral therapies to patients with [...]
Celldex Provides Corporate Update and Reports First Quarter 2019 Results
07/05/2019
HAMPTON, N.J., May 07, 2019 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported business and financial highlights for the first quarter ended March 31, 2019. “Celldex presented positive data [...]
Verrica Pharmaceuticals Reports First Quarter 2019 Financial Results
07/05/2019
-Reported positive topline data from pivotal Phase 3 clinical trials of VP-102 for the treatment of molluscum contagiosum -Preparing to submit NDA in second half of 2019 WEST CHESTER, Pa., May 07, 2019 (GLOBE NEWSWIRE [...]
Novelion Therapeutics Reports First Quarter 2019 Financial Results
07/05/2019
Company reiterates 2019 guidance of total net revenues between $160.0 and $175.0 million, including approximately $30.0 million of licensing revenues VANCOUVER, British Columbia, and CAMBRIDGE, Mass., May 07, 2019 ( [...]
Cara Therapeutics Reports First Quarter 2019 Financial Results
07/05/2019
– Conference call today at 4:30 p.m. ET – STAMFORD, Conn., May 07, 2019 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical [...]
Iovance Biotherapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update
07/05/2019
- First patient dosed in pivotal Cohort 4 in study of lifileucel in advanced melanoma; regulatory submission planned for late 2020 - - New interim data from melanoma Cohort 2 and cervical cancer studies to be presented [...]
Xenon Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Corporate Update
07/05/2019
Company Reports Advancements in Neurology-Focused Pipeline and Anticipates Multiple Products in Phase 2 or Later Stage Development this Year Conference Call at 4:30 pm ET Today BURNABY, British Columbia, May 07, 2019 ( [...]
Aptose Reports Results for the First Quarter Ended March 31, 2019
07/05/2019
─ Patient Dosed at Second Dose Level in APTO-253 Clinical Trial ─ ─ Patient Screening Initiated for CG-806 Clinical Trial ─ Conference Call and Webcast at 5pm EDT Today SAN DIEGO and TORONTO, May 07, 2019 (GLOBE [...]
Allakos Announces Positive Results with AK002 in Patients with Severe Allergic Conjunctivitis
07/05/2019
-- Substantial reduction of patient reported symptoms and physician assessed signs and symptoms -- -- Improvements also observed in atopic dermatitis, asthma and allergic rhinitis -- -- Conference call and webcast today [...]
New AveXis data at AAN showed long-term durability of Zolgensma® in patients with spinal muscular atrophy (SMA) Type 1
07/05/2019
Interim long-term follow-up data showed all enrolled Cohort 2 patients maintained motor function and milestones achieved during the Phase 1 START trial Mean age of follow-up since dosing with Zolgensma ( onasemnogene [...]
Trevi Therapeutics Announces Pricing of Initial Public Offering
07/05/2019
NEW HAVEN, Conn., May 07, 2019 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (“Trevi”), a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious [...]
NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology
07/05/2019
WALTHAM, Mass., May 07, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,279,179 titled “Transcutaneous Electrical Nerve [...]
Medexus Pharmaceuticals Launches New Metoject® Subcutaneous 15mg Dosage for the Treatment of Rheumatoid Arthritis, Psoriasis and Psoriatic Arthritis in Canada
07/05/2019
MONTREAL, May 07, 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP, OTCQB: PDDPF), today announced the launch of a new Metoject® Subcutaneous 15mg dose in Canada. Metoject [...]

Pages